Amgen plows ahead with costly, highly toxic cancer dosing despite FDA challenge

  • Post author:
  • Post category:uncategorized

When doctors began using the drug sotorasib in 2021 with high expectations for its innovative approach to attacking lung cancer, retired medical technician Don Crosslin was an early beneficiary.